LINEARIS

What this means for you

Approved and waiting on proof of use. It will register unless the applicant drops it, and its 18 Jun 2024 filing date already counts against anyone who files later.

Record

Serial number

79404811

Mark type

Stylized text

Filed

18 Jun 2024

Published for opposition

17 Mar 2026

Attorney of record

Peter S. Weissman

Goods and services

• Class 044 — Medical, beauty and agricultural services: Providing analysis, evaluation, and reporting of cancer test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of diabetes test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of antimicrobial resistance test results to help healthcare professionals determine a patient's clinical diagnosis; providing analysis, evaluation, and reporting of test results to help healthcare professionals determine a patient's clinical diagnosis; providing medical information in the treatment and prevention of metabolic diseases and disorders; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; providing cancer screening services; diabetes screening services; medical screening services relating to cardiovascular disease; medical screening services relating to metabolomic diseases; providing information in the field of general health and wellness via a website; providing information relating to health and wellness, namely, diabetes; genomic medical analysis services for cancer diagnostic purposes provided by medical laboratories and for treatment monitoring purposes to measure toxicity of treatment and response of treatment; proteomic and metabolomics medical analysis services for diabetes and antimicrobial resistance, diagnosis and treatment; medical screening; providing information relating to the preparation and dispensing of medications; pharmaceutical and drug review services of others in the nature of information relating to pharmaceutical and drug treatments and the toxicity of such treatments for diagnostic purposes; medical analysis services for diagnostic and treatment purposes provided by medical laboratories using diagnostic biomarkers for use in assessment of genomic, proteomic and metabolomics analysis for scientific, education and clinical use; remote monitoring of medical data for medical diagnosis and treatment; analysis and processing of blood plasma, stem cells, red blood cells, white blood cells, blood platelets and urine being medical services

Owner

• LINEARIS LABS INC., CA
• LINEARIS LABS INC., CA

Prosecution history

• 17 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
• 17 Mar 2026 — PUBLISHED FOR OPPOSITION
• 11 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
• 05 Mar 2026 — NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
• 23 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 23 Feb 2026 — EXAMINER'S AMENDMENT ENTERED
• 23 Feb 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 23 Feb 2026 — EXAMINERS AMENDMENT E-MAILED
• 23 Feb 2026 — EXAMINERS AMENDMENT -WRITTEN
• 18 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
• 18 Feb 2026 — NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
• 09 Dec 2025 — NOTIFICATION FOR REQ FOR RECON DENIED NO APPEAL FILED
• 09 Dec 2025 — ACTION FOR REQ FOR RECON DENIED NO APPEAL FILED E-MAILED
• 09 Dec 2025 — ACTION REQ FOR RECON DENIED NO APPEAL FILED COUNTED NOT MAILED
• 17 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED